Early data on Moderna's COVID-19 vaccine insufficient: Stat News

[progree]

Source: Reuters

Data from a small, early-stage safety trial testing Moderna Inc’s experimental COVID-19 vaccine does not provide critical data to assess its effectiveness, Stat News reported on Tuesday, citing experts.

The health news publication's report bit.ly/36kKerh pulled down shares of the Cambridge, Massachusetts-based biotech and erased modest gains on the benchmark S&P 500 index.

Moderna said on Monday the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers.

The news based on data from eight people who took part in a 45-subject safety trial sent the company’s shares up nearly 20% on Monday and also pushed the markets higher.

Read more: https://www.reuters.com/article/us-health-coronavirus-moderna/early-data-on-modernas-covid-19-vaccine-insufficient-stat-news-idUSKBN22V2ZH

---

Here's the StatNews report for deep divers:

Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine, StatNews, 5/19/20

https://www.statnews.com/2020/05/19/vaccine-experts-say-moderna-didnt-produce-data-critical-to-assessing-covid-19-vaccine/

-------------------------------------------------------

It's reported success was the biggest reason I've seen given for yesterday's 912 point run-up on the Dow.

The Dow quickly dropped after the news came out this afternoon, closing down 390 points.